Real-time enrollment status for this metastatic castration-resistant prostate carcinoma clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 12:35 AM UTC
| NCT Number | NCT07200830 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-Resistant Prostate Carcinoma |
| Phase | PHASE3 |
| Target Enrollment | 1,524 participants |
| Active Locations | 112 sites in the US |
| Sponsor | Alliance for Clinical Trials in Oncology |
| Last Updated on CT.gov | August 5, 2026 (3 weeks ago) |
As of August 30, 2026: Clinical trial NCT07200830 is currently recruiting participants. This phase3 study for metastatic castration-resistant prostate carcinoma is actively seeking new participants at 112 locations across the United States. The study is sponsored by Alliance for Clinical Trials in Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07200830 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 112 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07200830 was last updated 3 weeks ago (August 5, 2026). HelloStudys verifies this status automatically.